Cooperative Agreement to Support Effective Dissemination of Clinical Practice Guidelines
🏛 Food and Drug Administration (HHS-FDA)
✓ Free, no account · Source: Grants.gov · Last verified Jul 15, 2026
Can you apply?
This grant is for organizations seeking to disseminate FDA clinical practice guidelines. Eligible recipients typically include 501(c)(3) nonprofits, academic institutions, medical societies, and healthcare organizations. The program supports projects that improve healthcare provider awareness and adoption of evidence-based clinical guidelines. Applicants must demonstrate capacity to reach target audiences and implement effective dissemination strategies.
Geographic scope is national. Activities include developing educational materials, conducting training programs, and evaluating guideline adoption outcomes. Organizations must partner with FDA or have FDA-reviewed dissemination plans.
Not the right fit? Find grants for your organization in 5 questions →
Program description
To support dissemination of clinical practice guidelines, particularly those whose development was previously supported by FDA cooperative agreements. Applicants must propose a comprehensive plan to develop, evaluate, and distribute materials to facilitate dissemination, with a focus on equity.
Who can apply
Eligible applicants
How to apply
Application links
Required documents
- SF-424 (Application for Federal Assistance)
- Project narrative describing dissemination strategy
- Budget and budget narrative
- Organizational capacity documentation
- Letters of support from partner organizations
- Evaluation plan with measurable outcomes
- Evidence of FDA guideline review and alignment
Program contact
- 👤 Terrin Brown Grantor
- 📧 terrin.brown@fda.hhs.gov
- 📞 2404027610
Funding track record
Recent awards under CFDA 93.103 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$121,795,918
-
$76,105,626
-
$50,217,964
-
$47,940,304
-
$36,000,000
-
$35,573,997
-
$35,391,995
-
$30,732,300
-
$23,332,999
-
$21,347,288
Top States by Funding
- AZ 3 awards $131.4M
- MD 7 awards $108.7M
- CA 9 awards $106.5M
- VA 5 awards $96.6M
- PA 10 awards $77.4M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.103). How funding has trended year over year.
| 2016 | $170,482,435 | |
| 2017 est. | $208,900,832 | |
| 2018 | $173,077,408 | |
| 2019 | $198,507,896 | |
| 2020 | $212,448,590 | |
| 2021 | $218,918,739 | |
| 2022 est. | $255,910,458 | |
| 2023 est. | $246,894,600 |
FAQ
Who is eligible to apply for this grant?
501(c)(3) nonprofits, academic medical centers, and healthcare professional organizations can apply. Some applications may require 501(c)(3) status or nonprofit status to be competitive.
What types of activities does this grant fund?
Eligible activities include developing guideline dissemination materials, conducting training, creating implementation toolkits, and evaluating healthcare provider adoption of FDA clinical practice guidelines.
What is the typical funding range?
Cooperative agreements typically range from $100,000 to $500,000 annually, though specific amounts vary by program year and project scope.
How competitive is this grant?
This is a moderately competitive program. Success requires strong partnerships with healthcare providers, clear dissemination strategy, and demonstrated capacity to reach target audiences effectively.
When is the application deadline?
Check Grants.gov or FDA's grants page for the current funding announcement. Deadlines vary by program year and are typically announced 2-3 months before the submission date.
💡 Tips for applicants
- Align your dissemination approach directly with FDA's priority clinical guidelines; review FDA's clinical guidance documents before writing.
- Include letters of commitment from healthcare facilities, professional associations, or provider networks that will help distribute guidelines.
- Develop clear metrics to measure healthcare provider awareness, knowledge, and guideline adoption rates.
- Use plain language and visual tools when designing materials for busy clinicians and healthcare settings.
- Budget for evaluation activities; reviewers expect robust outcome measurement and reporting plans.
⚠️ Common mistakes
Applications fail when they lack credible partnerships with healthcare providers or lack realistic dissemination reach. Weak evaluation plans that don't measure actual guideline adoption (not just material distribution) get rejected. Proposals without clear FDA alignment or that don't address identified implementation barriers struggle.
Similar grants
- CLOSED FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) — Food and Drug Administration
- OPEN Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) — National Institutes of Health
- ROLLING Critical Path Public Private Partnerships Clinical Trials Optional — Food and Drug Administration
- OPEN Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) — National Institutes of Health
- OPEN Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) — National Institutes of Health